ClinicalTrials.gg
Active, not recruitingNCT07558655Updated Apr 30, 2026

The Glean Registry

An observational study in Urology and Urodynamics, sponsored by Bright Uro. Active, not recruiting at 1 site in United States. Open to participants aged 22 Years and older. Per ClinicalTrials.gov, last updated 2026-04-30.

Sponsored by Bright Uro · Observational

Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
500
Ages
22 Years and older
Sex
All
01

Study summary

A registry designed to collect real-world data (RWD) on the Glean Urodynamics System via a retrospective medical chart review.

02

Conditions studied

  • Urology
  • Urodynamics
03

In context

Lead sponsor

Bright Uro is the lead sponsor of 5 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Male and female adults age 22 year or older who underwent Glean Urodynamics.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female adult age 22 years or older
  • Underwent UDS testing using the Glean Urodynamics System
  • Glean UDS has been interpreted by the clinician

Exclusion criteria

Exclusion Criteria:

- Did not have both pressure and flow urodynamic parameters recorded using Glean.

05

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
500 participants (estimated)
Patient registry
No

Interventions

  • DeviceGlean Urodynamics System

    Glean Urodynamics System including pressure and flow measurements, and software apps.

06

What researchers measure

Primary outcomes

  1. Collection of Demographic and Procedural Information on Patients Who Underwent Glean Urodynamics

    Time frame: Perioperative/Periprocedural

07

Study locations

1 site
  • Palmetto Adult and Children's Urology
    North Charleston, South Carolina 29406, United States
08

References and documents

Publications

  • Hamson M, Maahs T, Poulsen A, Nowroozi B, Shamkhalichenar H, Carter BU, Takayoshi T, Flores D, Wibowo H. Comparative Pressure Measurement Performance of the Glean Urodynamics System-a Novel Wireless and Catheter-Free Urodynamics Device. J Endourol. 2026 Mar 11:8927790261430997. doi: 10.1177/08927790261430997. Online ahead of print. PubMed 41810746 ↗
  • Kim J, Xavier K, Cannon-Smith T, Vaughan T, Vemulapalli S, Zhao H, Aalami-Harandi A, Shah N. The Feasibility and Safety of the Glean Urodynamics System: The Modern Urodynamics System Efficacy Study. J Endourol. 2025 Jun;39(6):625-634. doi: 10.1089/end.2025.0270. Epub 2025 May 2. PubMed 40314068 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07558655
Lead sponsor
Bright Uro
Responsible party
Sponsor
First posted
Apr 30, 2026
Start date
Apr 16, 2026
Primary completion
May 2027 (estimated)
Completion
May 2027 (estimated)
Last update
Apr 30, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion